Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/86762
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuchovecky, C.-
dc.contributor.authorTurley, S.-
dc.contributor.authorBrown, H.-
dc.contributor.authorKyle, S.-
dc.contributor.authorMcDonald, J.-
dc.contributor.authorLiu, B.-
dc.contributor.authorPieper, A.-
dc.contributor.authorHuang, W.-
dc.contributor.authorKatz, D.-
dc.contributor.authorRussell, D.-
dc.contributor.authorShendure, J.-
dc.contributor.authorJustice, M.-
dc.date.issued2013-
dc.identifier.citationNature Genetics, 2013; 45(9):1013-1022-
dc.identifier.issn1061-4036-
dc.identifier.issn1546-1718-
dc.identifier.urihttp://hdl.handle.net/2440/86762-
dc.description.abstractMutations in MECP2, encoding methyl CpG-binding protein 2, cause Rett syndrome, the most severe autism spectrum disorder. Re-expressing Mecp2 in symptomatic Mecp2-null mice markedly improves function and longevity, providing hope that therapeutic intervention is possible in humans. To identify pathways in disease pathology for therapeutic intervention, we carried out a dominant N-ethyl-N-nitrosourea (ENU) mutagenesis suppressor screen in Mecp2-null mice and isolated five suppressors that ameliorate the symptoms of Mecp2 loss. We show that a stop codon mutation in Sqle, encoding squalene epoxidase, a rate-limiting enzyme in cholesterol biosynthesis, underlies suppression in one line. Subsequently, we also show that lipid metabolism is perturbed in the brains and livers of Mecp2-null male mice. Consistently, statin drugs improve systemic perturbations of lipid metabolism, alleviate motor symptoms and confer increased longevity in Mecp2 mutant mice. Our genetic screen therefore points to cholesterol homeostasis as a potential target for the treatment of patients with Rett syndrome.-
dc.description.statementofresponsibilityChristie M Buchovecky, Stephen D Turley, Hannah M Brown, Stephanie M Kyle, Jeffrey G McDonald, Benny Liu, Andrew A Pieper, Wenhui Huang, David M Katz, David W Russell, Jay Shendure & Monica J Justice-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.rights© 2013, Nature America Inc. All rights reserved.-
dc.subjectAnimals-
dc.subjectMice, Knockout-
dc.subjectMice-
dc.subjectRett Syndrome-
dc.subjectDisease Models, Animal-
dc.subjectCholesterol-
dc.subjectCodon, Terminator-
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subjectChromosome Mapping-
dc.subjectBehavior, Animal-
dc.subjectMutation-
dc.subjectQuantitative Trait Loci-
dc.subjectFemale-
dc.subjectMale-
dc.subjectMethyl-CpG-Binding Protein 2-
dc.titleA suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome-
dc.typeJournal article-
dc.identifier.doi10.1038/ng.2714-
pubs.publication-statusPublished-
dc.identifier.orcidBrown, H. [0000-0001-6342-3316]-
Appears in Collections:Aurora harvest 7
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.